drugset / Trial / NCT03437265
A Pharmacokinetic Study of PLENVU® in Healthy Subjects
NaSingle-groupOpen-labelTreatment
Summary
This study characterises the pharmacokinetic (PK) profile of the active ingredients of PLENVU (NER1006) and their related substances/metabolites. Subjects will receive PLENVU.
Timeline
- Start
- 2020-09-03
- Primary completion
- 2020-10-05
- Completion
- 2020-10-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Plenvu | Unknown | 101.91 g | Oral |
| Subject | Plenvu | Unknown | 115.96 g | Oral |
Indications
No indication recorded.